Persistent vancomycin-resistant Enterococcus faecium bacteremia

Infectious Diseases in Clinical Practice

Volumn 6, Issue 4, 1997, Pages 250-255

  Lukashok, Sophie A ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPICILLIN; AZTREONAM; BACTERICIDE; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN; DOXYCYCLINE; GENTAMICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PRISTINAMYCIN; STREPTOMYCIN; TIMENTIN; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIOSTASIS; BACTERIUM ISOLATION; BLOOD CULTURE; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; TREATMENT OUTCOME;

EID: 0030990510     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199705000-00010     Document Type: Article

References (13)

1. CDC. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
2. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1122-33.
3. Spera RV, Farber BF. Multiply-resistant Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA 1992; 268:2564.
4. Livomese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
5. Moellering RC Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1175-8.
6. Montecalvo MA, Horwitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1225-1229.
7. Spera RV, Farber BF. Multidrug-resistant Enterococcus faecium: an untreatable nosocomial pathogen. Drugs 1994;48:678-88.
8. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995;20: 1137-44.
9. Willey BM, Kreiswirth BN, Simor AE, et al. Detection of vancomycin resistance in Enteroccocus species. J Clin Microbiol 1992;30:1621-4.
10. Swenson JM, Clark NC, Ferraro MJ, et al. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 1994;32:1700-4.
11. Caron F, Pestel M, Kitzis MD, et al. Comparison of different β-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly β-lactam-resistant and highly glycopeptide resistant isolate of Enterococcus faecium. J Infect Dis 1995;171:106-12.
12. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium and vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663-70.
13. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in orthotopic liver transplant patients: risk factors for infection and mortality in infected vs. non-infected patients [abstract J73]. In: Proceedings and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1995: San Francisco (CA). Washington (DC): American Society for Microbiology, 1995:270.